Significance of an increase in the Child-Pugh score after radiotherapy in patients with unresectable hepatocellular carcinoma

Table 1 Clinical characteristics

Variables	n	(%)
Gender
Male	80	77.7
Female	23	22.3
Age (year)
Median	59
Range	21-80
ECOG
0	38	36.9
1	65	63.1
Hepatitis
None	2	1.9
HBV	73	70.9
HCV	9	8.7
NBNC	9	8.7
Alcoholic	10	9.7
Liver cirrhosis
No	32	31.1
Yes	71	68.9
PVTT
No	45	43.7
Yes	58	56.3
AFP (IU/mL)
≤ 400	67	65.0
> 400	36	35.0
Child-Pugh class before radiotherapy
A	91	88.3
B	12	11.7
AJCC stage
II	14	13.6
III	81	78.6
IVA	8	7.8
Previous treatment
None	7	6.8
TACE	95	92.2
RFA	8	7.8
PEI	8	7.8
Chemotherapy	14	13.6

Abbreviations: ECOG PS Eastern Cooperative Oncology Group performance status, HBV hepatitis B virus, HCV hepatitis C virus, NBNC non-B, non-C, PVTT portal vein tumor thrombosis, AFP alpha-fetoprotein, AJCC American Joint Committee on Cancer, TACE transcarterial chemoembolization, RFA radiofrequency ablation, PEI percutaneous ethanol injection.

ISSN: 1748-717X